CAPTRUST Financial Advisors
MDGL icon

CAPTRUST Financial Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878K Buy
1,635
+205
+14% +$105K ﹤0.01% 1820
2026
Q1 		$749K Buy
1,430
+299
+26% +$143K ﹤0.01% 1773
2025
Q4 		$659K Buy
1,131
+565
+100% +$289K ﹤0.01% 1742
2025
Q3 		$260K Buy
+566
New +$211K ﹤0.01% 2276
2024
Q1 		– Sell
-1,474
Closed -$341K – 2445
2023
Q4 		$341K Buy
+1,474
New +$258K ﹤0.01% 2017
2023
Q3 		– Sell
-3,173
Closed -$733K – 2680
2023
Q2 		$733K Buy
+3,173
New +$859K ﹤0.01% 1402
2022
Q3 		– Sell
-173
Closed -$12K – 3224
2022
Q2 		$12K Buy
173
+1
+0.6% +$74 ﹤0.01% 3654
2022
Q1 		$17K Buy
172
+45
+35% +$3.79K ﹤0.01% 3490
2021
Q4 		$11K Buy
127
+3
+2% +$246 ﹤0.01% 3661
2021
Q3 		$10K Sell
124
-11
-8% -$950 ﹤0.01% 3612
2021
Q2 		$13K Buy
135
+34
+34% +$4.03K ﹤0.01% 3382
2021
Q1 		$12K Buy
101
+4
+4% +$466 ﹤0.01% 3338
2020
Q4 		$11K Sell
97
-1,554
-94% -$190K ﹤0.01% 2524
2020
Q3 		$195K Buy
1,651
+97
+6% +$10.5K ﹤0.01% 1042
2020
Q2 		$174K Hold
1,554
– – ﹤0.01% 1095
2020
Q1 		$94K Buy
+1,554
New +$129K ﹤0.01% 1146
2019
Q4 		– Sell
-1,554
Closed -$134K – 1469
2019
Q3 		$134K Hold
1,554
– – ﹤0.01% 674
2019
Q2 		$163K Buy
+1,554
New +$166K 0.01% 606
2018
Q2 		– Sell
-41
Closed -$4K – 1568
2018
Q1 		$4K Sell
41
-57
-58% -$7.04K ﹤0.01% 1182
2017
Q4 		$9K Buy
+98
New +$5.6K ﹤0.01% 1019

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAPTRUST Financial Advisors's MDGL Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Madrigal Pharmaceuticals (MDGL) stake by 14% in Q2 2026, buying an estimated $105K and bringing the position to 1,635 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

CAPTRUST Financial Advisors first reported a position in MDGL in Q4 2017 and has held it in 20 quarters since. 415 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • CAPTRUST Financial Advisors held 1,635 shares of Madrigal Pharmaceuticals worth $878K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 205 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $105K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1820 holding.
  • CAPTRUST Financial Advisors first reported a position in Madrigal Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • 415 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.